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Pseudomonas aeruginosa is a leading cause of hospital-acquired pneumonia and chronic lung infections in cystic fibrosis pa-
tients. Iron is essential for bacterial growth, and P. aeruginosa expresses multiple iron uptake systems, whose role in lung infec-
tion deserves further investigation. P. aeruginosa Fe3 uptake systems include the pyoverdine and pyochelin siderophores and
two systems for heme uptake, all of which are dependent on the TonB energy transducer. P. aeruginosa also has the FeoB trans-
porter for Fe2 acquisition. To assess the roles of individual iron uptake systems in P. aeruginosa lung infection, single and dou-
ble deletion mutants were generated in P. aeruginosa PAO1 and characterized in vitro, using iron-poor media and human se-
rum, and in vivo, using a mouse model of lung infection. The iron uptake-null mutant (tonB1 feoB) and the Fe3 transport
mutant (tonB1) did not grow aerobically under low-iron conditions and were avirulent in the mouse model. Conversely, the wild
type and the feoB, hasR phuR (heme uptake), and pchD (pyochelin) mutants grew in vitro and caused 60 to 90%mortality in
mice. The pyoverdine mutant (pvdA) and the siderophore-null mutant (pvdA pchD) grew aerobically in iron-poor media but not
in human serum, and they caused lowmortality in mice (10 to 20%). To differentiate the roles of pyoverdine in iron uptake and
virulence regulation, a pvdA fpvR double mutant defective in pyoverdine production but expressing wild-type levels of pyover-
dine-regulated virulence factors was generated. Deletion of fpvR in the pvdA background partially restored the lethal phenotype,
indicating that pyoverdine contributes to the pathogenesis of P. aeruginosa lung infection by combining iron transport and vir-
ulence-inducing capabilities.
Pseudomonas aeruginosa is a leading cause of hospital-acquiredinfections and the main bacterial pathogen responsible for se-
vere lung deterioration in cystic fibrosis (CF) patients. Among
hospital-acquired P. aeruginosa infections, ventilator-associated
pneumonia is a major clinical entity, with20% prevalence and
dramatically highmortality andmonetary costs (1, 2).Other com-
mon syndromes associated with P. aeruginosa lung infection are
those occurring in patients with chronic lung disease, such as
chronic obstructive pulmonary disease andCF (3). All CF patients
experience P. aeruginosa lung infection during their lifetime, and
more than 80% of them become chronically infected in the adult
years (3, 4). Lifelong P. aeruginosa infection causes decreases in
lung function and poor clinical scores for CF patients, ultimately
resulting in a fatal prognosis (5).
Like most bacterial pathogens, P. aeruginosa needs substantial
amounts of iron to infect the host andmultiply within tissues and
body fluids. Under normal in vivo conditions, iron is not readily
available due to sequestration in iron binding proteins, such as
transferrin in serum and lactoferrin in mucosal secretions, which
are components of the innate immunity and provide a forefront
“nutritional” defense against invading pathogens (6). On the
other hand, P. aeruginosa has an impressive capacity to retrieve
iron from a variety of natural sources through a multiplicity of
systems for the active transport of iron compounds into the cell (7,
8). First of all, P. aeruginosa produces two siderophores, pyover-
dine and pyochelin, endowed with very different structural and
functional properties, and both are capable of chelating ferric ions
(Fe3). Pyoverdine is a peptidic siderophore containing two hy-
droxamic groups and a fluorescent dihydroxyquinoline chro-
mophore, which create a very efficient iron coordination center
(9–11), while pyochelin is a salicylate-based siderophore with a
lower affinity for iron (12, 13). Both siderophores are actively
translocated across the outer membrane upon binding to specific
receptors, namely, the FptA and FpvA outer membrane proteins
for pyochelin and pyoverdine transport, respectively (14). P.
aeruginosa can also assimilate heme, which may be released by
hemoproteins during infection, through theHas andPhu systems.
While Phu accounts for direct heme uptake via the PhuR receptor,
the Has system relies on a secreted hemophore protein, HasA,
which catches heme and delivers it to the HasR outer membrane
receptor (15). Translocation of all these iron carriers through the
cognate receptor requires the consumption of the proton motive
force by the TonB-ExbB-ExbD protein complex, which serves as
an energy coupler for active transport across the outer membrane
(16). While P. aeruginosa PAO1 carries three different tonB genes
(tonB1, tonB2, and tonB3), tonB1 has been demonstrated to play
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the main role in siderophore-mediated iron uptake (17–19). Ad-
ditionally, the P. aeruginosa genome encodes more than 30 TonB-
dependent outer membrane receptors, some of which are impli-
cated in the uptake of xenosiderophores (i.e., siderophores
produced by other microorganisms, such as ferrichrome or defer-
oxamine) or other, still uncharacterized exogenous iron carriers
(20, 21). In addition to TonB-dependent iron uptake systems, P.
aeruginosa has the ability to acquire ferrous iron (Fe2) via the
TonB-independent Feo system, whose main component is the
FeoB permease, located in the cytoplasmic membrane and con-
taining a cytosolic N-terminal domain with GTPase activity (22).
Active iron uptake is shut off in the presence of sufficient in-
tracellular iron, and the Fur repressor protein sits atop the iron
regulation hierarchy, sensing the intracellular levels of the core-
pressor Fe2 and directly or indirectly repressing the transcription
of almost all genes related to iron uptake (23, 24). Most of the P.
aeruginosa iron uptake systems have a second level of regulation,
resulting from autoinduction of iron uptake genes, which takes
place when the iron carrier is effectively internalized by the cell (8,
21, 24). The best-studied autoregulatory system is the pyoverdine
surface signaling cascade, in which ferripyoverdine binding to the
FpvA receptor transmits a signal to the cytoplasm via the mem-
brane-bound anti-sigma factor protein FpvR, which ultimately
results in activation of both the FpvI and PvdS sigma factors.
While the transcriptional specificity of FpvI is restricted to the
fpvA receptor gene, the PvdS sigma factor governs, either directly
or indirectly, the expression of several genes forming the PvdS
regulon. These include pyoverdine biosynthetic genes as well as
genes encoding major P. aeruginosa virulence factors, such as the
PrpL protease and exotoxin A (25, 26). Thus, pyoverdine is pre-
dicted to have dual roles in P. aeruginosa virulence: (i) it provides
bacteria with an essential nutrient for in vivo growth and (ii) it
serves as a signal molecule for the expression of major virulence
factors, which in turnmay contribute to increased iron availability
to bacteria during infection (21, 25).
The importance of iron for P. aeruginosa infection was first
highlighted using an intraperitoneal mouse infection model (27),
and pyochelinwas shown to increaseP. aeruginosa lethality during
intraperitoneal infection (28). Thereafter, a number of studies
were performed to ascertain the roles of individual P. aeruginosa
siderophores in infectivity and virulence. Pyoverdine-deficient P.
aeruginosa mutants were less virulent than the wild type in the
burned-mouse model (29), and the PvdS sigma factor was dem-
onstrated to play a prominent role in both rabbit endocardial
infection and mouse lung infection (30, 31). However, intranasal
inoculation into immunosuppressed mice revealed no significant
difference in lethality at 48 h between wild-type PAO1 and the
pyochelin- or pyoverdine-deficient mutant or the double mutant,
though the mouse killing kinetics and bacterial counts in blood
suggested that virulence and invasive capacity were attenuated in
siderophore mutants (32). More importantly, it was shown that
tonB1 inactivation severely impaired the capacity of P. aeruginosa
to multiply in the muscles and lungs of immunosuppressed
mice (17), suggesting that active transport of ferric compounds
is an essential component of the P. aeruginosa virulence arma-
mentarium.
In this work, we compared the contributions of individual iron
uptake systems to P. aeruginosa virulence by using a well-estab-
lished mouse model of P. aeruginosa lung infection (33, 34). For
this purpose, deletion mutants in the major iron uptake systems
were generated in P. aeruginosa PAO1, and their iron uptake and
virulence phenotypes were characterized in vitro and in vivo. We
demonstrated that P. aeruginosa thrives in an iron-poor environ-
ment in mouse lungs at the onset of infection and that individual
iron uptake systems have different abilities to promote lethal dis-
ease in mice, according to the following hierarchy: pyoverdine
pyochelin  ferrous iron uptake  heme uptake. Our findings
confirm that ferric iron uptake is essential for P. aeruginosa lung
infection and provide novel in vivo evidence of the dual roles of
pyoverdine as a primary siderophore and a virulence-inducing
signal molecule.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions.Bacterial strains and
plasmids used in this work are listed in Table 1. Escherichia coli and P.
aeruginosa were routinely grown in Luria-Bertani (LB) medium (35) or
on LB agar plates for general genetic procedures. P. aeruginosawas grown
in the followingmedia for specific iron uptake assays: iron-depleted Bacto
Casamino Acids (Becton Dickinson, Sparks, MD)medium (DCAA) (36),
Trypticase soy broth (Neogen Co., Lansing, MI) dialysate medium
(TSBD) (37),M9minimalmedium (31) supplementedwith 0.2% glucose
as the carbon source and 0.1 or 1.0mM2,2=-dipyridyl (DIP) (Sigma) as an
iron chelator, and GGP medium (38). DCAA was supplemented with 1
mMNaHCO3 for growth experiments in the presence of transferrin. Apo-
transferrin (iron-free; Sigma) was dissolved in DCAA supplemented with
10 mM NaHCO3 buffered at pH 7.5 with acetic acid to obtain a final
concentration of 2.5 mg/ml, equivalent to 31.3 M apo-transferrin
(DCAA-Tf). For all the media used, iron-sufficient conditions were ob-
tained by adding FeCl3 or FeSO4 to the indicated concentrations.
For mutant construction, E. coli and P. aeruginosa strains were grown
in LB, with or without antibiotics, at 37 and 42°C, respectively, with vig-
orous aeration. For sucrose selection, LB containing 5% sucrose or LB
containing 5% sucrose and 40 M FeSO4 was used. When required, an-
tibiotics were added at the following concentrations for E. coli, with the
concentrations used for P. aeruginosa shown in parentheses: ampicillin,
100 g ml1; carbenicillin (250 g ml1); chloramphenicol, 30 g ml1
(375 g ml1); gentamicin, 10 g ml1 (200 g ml1); nalidixic acid, 20
g ml1; and tetracycline, 12.5 g ml1 (100 g ml1).
Genetic procedures. Unmarked in-frame deletion mutants in iron
uptake genes were constructed by suicide plasmid insertion mutagenesis
(39, 40). E. coli was used for recombinant DNA manipulations. The con-
structs for mutagenesis were generated by directional cloning into the
pEX18Tc or pDM4 vector (Table 1) (39, 40) of two DNA fragments of ca.
600 bp, encompassing the regions upstream and downstream of the se-
quence to be deleted. Fragments were amplified by PCR, digested with the
appropriate restriction enzymes, and cloned into pEX18Tc or pDM4,
generating the derivative vectors pEX18TcfeoB, pDM4hasR,
pDM4phuR, pDM4tonB1, and pDM4fpvR (Table 1). PCR primers
and restriction enzymes used for cloning of PCR products are listed in
Table S1 in the supplemental material. All constructs were verified by
DNA sequencing. Deletion vectors were conjugally transferred from E.
coli S17-1 pir into the P. aeruginosa PAO1 wild type or into suitable
deletion mutants to obtain the hasR phuR, tonB1 feoB, and pvdA fpvR
double mutants. The in-frame deletion mutations were obtained by re-
combination as described previously (39, 40). To allow the growth of
tonB1-deficient strains, tonB1 transconjugants were selected in the pres-
ence of 40 M FeSO4, and both tonB1 and tonB1 feoB mutants were
routinely maintained in medium supplemented with 40 M FeSO4. All
the deletion events were verified by PCR using primers flanking the de-
leted region.
The pvdA, pchD, tonB1, hasR, and phuR mutations were comple-
mented in trans by supplying each coding sequence, along with the indig-
enous promoter region, on plasmid pUCP18 (41). DNA fragments were
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amplified by PCR using primers listed in Table S1 in the supplemental
material.
The mini-CTX1 PpvdA=-=mCherry construct was generated by clon-
ing the mCherry coding sequence without the start codon into the inte-
gration-proficient plasmid mini-CTX1 (42) by HindIII/SalI digestion,
yielding mini-CTX1 mCherry (Table 1). The DNA fragment encompass-
ing the pvdA promoter (from nucleotide277 to nucleotide10 relative
to the start codon of pvdA) was then cloned into mini-CTX1 mCherry by
EcoRI/HindIII digestion in order to generate mini-CTX1 PpvdA=-
=mCherry, harboring a translational fusion between the first three codons
TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid Genotype and/or relevant characteristics Reference or source
Strains
P. aeruginosa strains
PAO1 ATCC 15692 (wild type, prototroph) American Type Culture Collection
PAO1 PpvdA=-=mCherry Wild type with PpvdA::mCherry This work
pvdA mutant PAO1 pvdA 45
pchD mutant PAO1 pchD 82
pvdA pchD mutant PAO1 pvdA pchD 83
PAO1 pvdA pchD PpvdA=-=mCherry PAO1 pvdA pchD PpvdA::mCherry This work
fpvR mutant PAO1 fpvR This work
pvdA fpvR mutant PAO1 pvdA fpvR This work
pvdS mutant PAO1 pvdS Gmr 31
hasR phuR mutant PAO1 hasR phuR This work
feoB mutant PAO1 feoB This work
tonB1 mutant PAO1 tonB1 This work
tonB1 feoB mutant PAO1 tonB1 feoB This work
toxA mutant PAO1 phoA wp03q2B07 (mutant 40695) Transposon mutant collection of
University of Washington
Escherichia coli strains
DH5	 F= recA1 endA1 hsdR17 supE44 thi-1 gyrA96 relA1 (lacZYA-
argF)U169 
80dlacZM15 Nalr
35
S17-1 pir recA thi pro hsdR(M RP4)::2-Tc::Mu::Km Tn7 pir Tpr Smr 84
Plasmids
pEX18Tc Allelic exchange vector pMB1 replicon; oriT sacB lacZ	mob Tcr 39
pDM4 Suicide vector; sacBR oriR6K Cmr 40
pmCherry-1 Vector used as template for amplification of the mCherry coding
sequence
Clontech
Mini-CTX1 Promoter-probe vector;-FRT-attP-MCS ori int oriT Tcr 42
pFLP2 FLP recombinase-expressing plasmid; Apr 39
Mini-CTX1 mCherry Tcr This study
Mini-CTX PpvdA=-=mCherry Plasmid to insert a PpvdA-mCherry fusion into the chromosome of
P. aeruginosa; Tcr
This study
pDM4fpvR pDM4 derivative carrying the flanking regions of the fpvR coding
sequence
This study
pDM4hasR pDM4 derivative carrying the flanking regions of the hasR coding
sequence
This study
pDM4phuR pDM4 derivative carrying the flanking regions of the phuR coding
sequence
This study
pEXfeoB pEX18Tc derivative carrying a Gmr-GFP cassette between the feoB
flanking regions
This study
pDM4tonB pDM4 derivative carrying the flanking regions of the tonB1 coding
sequence
This study
pMP220::PfeoA pMP220 derivative carrying a PfeoA::lacZ transcriptional fusion; Tcr 31
pPZ-toxA pPZ20 derivative carrying a PtoxA::lacZ translational fusion; Cbr 26
pPZ-prpL pPZTC derivative carrying a PprpL::lacZ transcriptional fusion; Cbr 26
pUCP18 E. coli-Pseudomonas shuttle vector derived from pUC18; ColE1
pRO1600 Apr Cbr
41
pUCPpvdA pUCP18 derivative carrying the coding sequence of pvdA with its
own promoter
This study
pUCPpchD pUCP18 derivative carrying the coding sequence of pchD with its
own promoter
This study
pUCPtonB1 pUCP18 derivative carrying the coding sequence of tonB1 with its
own promoter
This study
pUCPphuRhasR pUCP18 derivative carrying the coding sequences of phuR and hasR
with their own promoters
This study
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of pvdA and the mCherry coding sequence, under the control of the pvdA
promoter (Table 1). The mini-CTX PpvdA=-=mCherry plasmid was con-
jugally transferred from E. coli S17-1 pir into P. aeruginosa strains to
allow integration of the construct into the attBneutral site of theP. aerugi-
nosa chromosome. Transconjugants were selected on tetracycline-con-
taining LB agar plates.
Growth in the presence of human transferrin and in human serum.
Human serum samples (2.5 ml each) were collected from 130 healthy
donors following submission, comprehension, and subscription of a writ-
ten informed consent. Sera were pooled, filtered, and heat inactivated (30
min at 56°C) as previously described (43). Serum chemistry was as fol-
lows: total iron, 0.78 g/ml; ferritin, 0.21 g/ml; transferrin, 2.63 mg/ml;
and total iron binding capacity, 3.16 g/ml (28% transferrin saturation,
equivalent to 45.6 M unsaturated iron binding sites). To achieve com-
plete transferrin saturation, an excess of FeCl3 (100 M) was added to
bothDCAA-Tf and human serum. Bacterial strains were grown overnight
at 37°C inDCAA, diluted to an optical density at 600 nm (OD600) of 0.003
in DCAA-Tf or human serum, with or without FeCl3, and dispensed into
96-wellmicrotiter plates. Growth (OD600) wasmonitored periodically for
up to 48 or 56 h in a Wallac 1420 Victor3 V multilabel plate reader
(PerkinElmer).
Growthundermicroaerobic conditions.P. aeruginosaPAO1and iso-
genic feoB, tonB1 feoB, and tonB1mutants containing the pMP220::PfeoA
plasmid (Table 1) were grown under low-oxygen conditions. Bacteria
were inoculated into 12 ml of TSBD containing 1% KNO3 (as a terminal
electron acceptor) and 2 mM ascorbate (as a reducing agent), dispensed
into 13-ml round-bottomed tubes (44), and topped with liquid paraffin,
while the tube caps were sealedwith Parafilm. TSBDwas supplemented or
not with FeSO4 (2.5, 10, or 50 M) or with DIP (100 M). Cultures were
incubated at 37°C under static conditions, and growth was measured by
determining the OD600 after 24 h.
Growth in the presence of heme. The ability of the PAO1 wild type
and the hasR phuR mutant to acquire heme was assessed as previously
described (15), with minor modifications. Strains were grown for 16 h at
37°C in M9 medium containing 0.2% glucose and 100 M DIP. The
cultureswere diluted to ca. 105 to 106 cellsml1, and 100l of each diluted
culture was mixed with 4mlM9medium containing 0.2% glucose, 1 mM
DIP, and 0.8% agarose (ultrapure agarose; Invitrogen) and poured onto
plates of M9 medium containing 0.2% glucose, 1 mM DIP, and 1.5%
agarose. Sterile filter disks were placed on top of the plates and spotted
with 15 l of a 5-mg ml1 stock solution of bovine hemin chloride
(Sigma) in 10 mM NaOH or bovine hemoglobin (Sigma) in phosphate-
buffered saline (PBS). The appearance of colonies around the filter disks
was detected after 48 h of incubation at 37°C.
Siderophore assays. Pyoverdine production after 14 h of growth in
DCAA (inoculum OD600 0.001) was measured in culture supernatants
appropriately diluted in 100mMTris-HCl (pH 8) by absorbance readings
at 405 nmnormalized to the cell densities of the bacterial cultures (OD600)
(45). For pyoverdine purification, the P. aeruginosa PAO1 pchD mutant
was grown in 30 ml of DCAA at 37°C for 24 h. Pyoverdine was purified
from the culture supernatant by filtration through a Sep-Pack C18 Vac
cartridge (3 ml; Waters). After solvation of the polymer packing with 10
hold-up volumes of 50% methanol, the cartridge was flushed with 10
hold-up volumes of double-distilled water. The filtered culture superna-
tant containing pyoverdine was loaded onto the column and washed sev-
eral times with double-distilled water. The pigmented fluorescent mate-
rial was then eluted with a small quantity of 50% (vol/vol) methanol,
evaporated to dryness in a desiccator, and dissolved in 100 l of double-
distilledwater. The pyoverdine concentrationwas determined by spectro-
photometric measurement of the apo form (OD405) (ε 1.4 10
4 M1
cm1) (46).
For pyochelinmeasurement, the PAO1wild type, the pvdA, pchD, and
pvdA pchDmutant strains, and the complementedmutants were grown in
GGP medium for 36 h. Pyochelin was partially purified by ethyl acetate
extraction of acidified supernatants and resuspended in methanol, and
extracts (2.5 or 5l) were separated by thin-layer chromatography (TLC)
(silica gel 60F254; Merck), using acetone:methanol:0.2 M acetic acid (5:
2:1) as the development solvent (47). Pyochelin spots on TLC plates were
detected by yellow-green fluorescence emission under UV light or upon
development by spraying with FeCl3, as described previously (36). Quan-
titative determination of pyochelin levels was performed by scraping the
fluorescent spots from TLC plates and extracting them twice with meth-
anol. The amount of apo-pyochelin in methanol extracts was determined
by spectrophotometricmeasurement (OD330) (ε 4.4 10
3M1 cm1)
(48).
Western blot analysis of ToxA expression and PrpL and -galacto-
sidase activity assays. For ToxA detection, cell-free culture supernatants
were supplemented with 6 SDS-PAGE loading dye (375 mM Tris-HCl
[pH 6.8], 9% SDS, 50% glycerol, 0.03%bromophenol blue). The volumes
of supernatants (or appropriate dilutions) loaded in SDS-PAGE gels were
normalized to bacterial growth according to the following formula: load-
ing volume (microliters) 10/OD600 for the corresponding bacterial cul-
ture (49). Proteins resolved by SDS-PAGE were electrotransferred to a
nitrocellulose filter (Hybond-C Extra; Amersham) and probed for ToxA
by using a rabbit polyclonal anti-ToxA antibody (Sigma-Aldrich). Filters
were developed with ECL Prime (Amersham) and visualized on a Chemi-
Doc XRS system (Bio-Rad). Densitometric analysis of band intensities
was performed using Image Lab 3.0 software (Bio-Rad).
PrpL enzymatic activity was determined for 50-l aliquots of cell-free
culture supernatants as previously described (50), using the chromogenic
substrate Chromozym PL (tosyl-Gly-Pro-Lys-p-nitroanilide; Sigma-Al-
drich), which is specific for PrpL (protease IV) and is not cleaved by other
P. aeruginosa proteases (51).
-Galactosidase activity from P. aeruginosa cells carrying the
pMP220::PfeoA, pPZ-toxA, or pPZ-prpL reporter plasmid (Table 1) was
determined spectrophotometrically by using o-nitrophenyl--D-galacto-
pyranoside as the substrate, normalized to the OD600 of the bacterial cul-
ture, and expressed in Miller units (M.U.) (52).
Mouse model of lung infection. To probe the iron availability in the
mouse lung, the fluorescent P. aeruginosa reporter strains PAO1 PpvdA=-
=mCherry and PAO1 pvdA pchDPpvdA=-=mCherrywere grown for 16 h in
DCAA and then diluted to ca. 6 107 and 6 108 CFU/ml, respectively,
in sterile PBS supplemented or not with 10 M FeSO4. Four groups of
four CD1male mice (Charles River) were infected intranasally with 80l
of bacterial suspension (2 inocula of 20 l per nostril) supplemented or
not with FeSO4. Two mice per group were sacrificed after 5 h, and the
other two 24 h after infection, and bronchoalveolar lavages (BALs) were
performed immediately to recover bacteria from the lungs. The presence
of bacterium-associated mCherry fluorescence in BAL fluid samples was
investigated by confocal microscopy (Leica SP5 confocal laser scanning
microscope; 63 oil immersion objective) at an excitation wavelength of
585 nm.
To investigate the contributions of individual iron uptake systems to
P. aeruginosa lung infectivity, the PAO1 wild type and isogenic single or
double mutants in iron uptake systems were grown for 16 h in TSBD
supplementedwith 5MFeSO4 to support growth of the tonB1 and tonB1
feoBmutants and then were transferred to fresh medium and grown for 4
to 5 h, to themid-log phase. The cultures were centrifuged at 4,000 g for
15 min, and the cell pellets were washed twice with PBS and suspended in
the original volume of liquid. The optical density was adjusted to obtain
the desired inocula, and P. aeruginosa agar beads were prepared following
an established method (33), using TSBD agar. C57BL/6 male mice
(Charles River) were infected intratracheally with ca. 106 cells of each P.
aeruginosa strain embedded in agar beads as described previously (33),
and mortality was monitored for up to 14 days.
Animals were handled in compliance with European Communities
Council Directive 86/609 for the care of laboratory animals and ethical
guidelines for research in animals. Procedures were approved by the In-
stitutional Animal Care and Use Committee (IACUC) of the San Raffaele
Scientific Institute (Milan, Italy) and the Department of Food Safety and
Iron and Pseudomonas aeruginosa Virulence
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Veterinary Public Health, Istituto Superiore di Sanità (Rome, Italy), and
adhered strictly to the ItalianMinistry ofHealth guidelines for the use and
care of experimental animals.
Statistical analysis. Statistical analysis was performed with GraphPad
Prism software, using one-way analysis of variance (ANOVA) (for growth
yield analysis) and the log rank Mantel-Cox test (for survival curve anal-
ysis). A first-type error probability of 0.05 was considered significant.
RESULTS
In vitro phenotypes of iron uptakemutants. To gain insight into
the role of iron in P. aeruginosa virulence, a set of mutants im-
paired in single or multiple iron uptake systems was generated in
the reference strain PAO1, and their phenotypes were tested. The
siderophoremutants, i.e., the pyoverdinemutant (pvdA), the pyo-
chelin mutant (pchD), and the siderophore-null double mutant
(pvdA pchD), were verified to lack pyoverdine and/or pyochelin
production in the iron-poor media DCAA and GGP (Fig. 1A and
B). The heme uptake mutant (hasR phuR) was verified to have
growth impairment in the presence of heme as the sole iron source
(Fig. 1C). The growth of all thesemutants was either unaffected or
moderately reduced in DCAA (Fig. 1; not shown for the hasR
phuR mutant). Conversely, growth of the Fe(III) uptake mutant
(tonB1) was impaired in DCAA unless the medium was supple-
mented with an excess of iron (Fig. 1D). Addition of pyoverdine,
pyochelin, or heme did not restore the growth of the tonB1 mu-
tant, while it slightly stimulated the growth of the wild type (Fig.
1D), consistent with the essential role of the TonB system in sid-
erophore and heme/hemophore translocation across the outer
membrane (16, 17). For all deletion mutants, the iron uptake-
defective phenotypes were rescued when a copy of the deleted
gene(s) with the indigenous promoter was provided in trans on
plasmid pUCP18 (see Fig. S1 in the supplemental material).
The feoB and tonB1 feoB Fe(II) uptakemutants were compared
with the corresponding parental strains (PAO1 and the tonB1mu-
tant, respectively) for the ability to grow in the iron-depleted me-
dium TSBD containing 1% KNO3 and 2 mM ascorbate under
both aerobic and microaerobic conditions (Fig. 2). To allow mi-
FIG 1 Iron uptake phenotypes of different P. aeruginosa iron uptakemutants. (A) Growth (bars; left y axis) and pyoverdine production (diamonds; right y axis)
of thewild-type (WT) strain and the pvdA, pchD, and pvdA pchDmutantsmeasured after 14 h of growth in the iron-poormediumDCAA. (B) Pyochelin extracted
fromculture supernatants of theWT, pvdA, pchD, and pvdApchD strains after 36 h of growth inGGPmediumand separated (2.5 or 5.0l of extract) by thin-layer
chromatography (TLC). Chromatograms were visualized by exposure to UV light (left) and by spraying with 100 M FeCl3 (right). (C) Growth of the WT and
hasR phuR strains in the presence of hemoglobin (left) or hemin (right) on M9 agarose plates containing 0.2% glucose and 1 mMDIP. (D) Growth (bars; left y
axis) of theWTand tonB1 strains at 24 h postinoculation inDCAA supplemented or notwith pyoverdine (PVD; 20M), pyochelin (PCH; 20M), hemin (heme;
20M), or FeCl3 [Fe(III); 50M]. Pyoverdine production (diamonds; right y axis) was measured in the control medium (DCAA) and in DCAA supplemented
with FeCl3 [Fe(III)]. Values in panels A and D are the means for three independent experiments standard deviations (SD). Pictures in panels B and C are
representative of three independent experiments giving similar results.
FIG 2 Role of the Feo system under aerobic and microaerobic growth condi-
tions. The graph shows the growth (bars; left y axis) and activity of the feoA::
lacZ iron-regulated fusion (circles; right y axis) of the wild type (WT) and the
feoB, tonB1, and tonB1 feoB mutants after 24 h of growth under aerobic and
microaerobic conditions in TSBD (supplemented with 1% KNO3 for mi-
croaerobic growth). Data are the means  SD for six independent experi-
ments. Statistical analysis (ANOVA followed by Tukey’s multiple-comparison
test) was performed on bacterial growth results, and statistically significant
differences with respect to the WT are indicated as follows: **, P 0.01; ***,
P 0.001.
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croaerobic growth of P. aeruginosa in TSBD, the terminal electron
acceptor KNO3 appeared to be essential (53, 54; data not shown).
Under aerobic conditions, growth of the tonB1 and tonB1 feoB
mutants was severely impaired in TSBD and was further inhibited
by the presence of the Fe(II) chelator DIP (Fig. 2), consistent with
our previous observations in DCAA (Fig. 1D). Under microaero-
bic conditions in the presence of the reducing agent ascorbate,
where Fe(II) is expected to represent the prevalent form of iron,
both the tonB1 and tonB1 feoBmutants grewwell, attaining nearly
the same levels as the corresponding parental strains (Fig. 2). Un-
expectedly, growth of the feoB and tonB1 feoB Fe(II) uptake mu-
tants was not significantly different from that observed for
wild-type PAO1 and the tonB1 mutant, respectively (Fig. 2). A
transcriptional fusion between lacZ and the promoter of the feo
operon (PfeoA), which is expected to be active under low-iron and
low-oxygen conditions (23, 55), was highly expressed by all the
tested strains, confirming that iron was limiting during mi-
croaerobic growth (Fig. 2).
Undermicroaerobic conditions, the addition of DIP (100M)
slightly reduced the growth of the feoBmutant with respect to that
of PAO1, while the growth of the tonB1 and tonB1 feoB strains was
completely inhibited (Fig. 2). Addition of increasing concentra-
tions of Fe(II) (2.5 to 50 M FeSO4) stimulated the growth of all
strains, although to a lesser extent for the tonB1 feoB mutant. As
expected, expression of the iron-regulated PfeoA::lacZ transcrip-
tional fusion was completely shut down at 50 M FeSO4 (Fig. 2).
Taken together, these results suggest the existence in P. aeruginosa
of an alternative route(s) for the acquisition of Fe(II) that enables
the feoBmutant to grow undermicroaerobic conditions in Fe(II)-
poor environments.
Efficacy of iron uptake systems in competing for iron with
human transferrin. To investigate the capability of P. aeruginosa
iron uptake systems to compete for iron with human transferrin,
wild-type PAO1 and the iron uptake mutants were tested for the
ability to grow in DCAA supplemented with human transferrin
(DCAA-Tf) at 2.5 mg/ml (approximately the transferrin concen-
tration in human serum) (see Materials andMethods for details).
The feoB, pchD, and hasR phuRmutant strains grew as well as the
PAO1 wild type in DCAA-Tf, while growth of both the pvdA and
pvdA pchD mutants was strongly reduced (Fig. 3A). Remarkably,
growth of both the tonB1 and tonB1 feoBmutants was completely
inhibited (Fig. 3A), suggesting that Fe(III) uptake systems are es-
sential in the competition with transferrin and that pyoverdine
plays the primary role. Addition of an excess of iron (100 M
FeCl3) ensured the growth of all mutants at levels comparable to
those of the wild type and much higher than those observed in
DCAA-Tf without added iron (Fig. 3A).
Growth of all strains was also tested in heat-inactivated human
serum, with or without 100 M FeCl3 (Fig. 3B). While growth of
the feoB, pchD, and hasR phuRmutants was comparable to that of
the wild type, neither the pvdA and pvdA pchD nor tonB1 and
tonB1 feoB mutants were able to grow in human serum unless
exogenous iron was added (Fig. 3B). In agreement with previous
findings (29, 56, 57), our data corroborate the crucial role of py-
overdine for P. aeruginosa growth in human serum and show that
the other iron uptake systems are dispensable under these growth
conditions.
Probing iron availability in themouse lung duringP. aerugi-
nosa infection. Before testing the virulence of P. aeruginosa iron
uptake mutants in a mouse model of experimental lung infection,
iron bioavailability in the mouse lung was assessed. For this pur-
pose, a reporter system based on the PvdS-controlled pvdA pro-
moter (58) fused to the gene for the fluorescent protein mCherry
(Table 1)was introduced into the genomes ofwild-type PAO1 and
the pvdA pchD double mutant (Fig. 4; see Fig. S2 in the supple-
mental material). Detectable fluorescence was associated with the
cells of both strains grown in DCAA and was absent upon growth
in DCAA containing 10 M FeSO4 (Fig. 4; see Fig. S2). Mice
were inoculated intranasally with 5 106 and 5 107CFUof each
of the fluorescent reporter strains grown in DCAA, andmCherry-
related fluorescence was assessed in bacterial cells recovered from
the BAL fluid of infected mice at 5 and 24 h postinfection. No
mortality was observed during infection (data not shown). Both
wild-type and pvdA pchD mutant cells carrying the PpvdA=-
=mCherry fusion appeared fluorescent when recovered from the
BAL fluid at 5 and 24 h postinfection, while fluorescence was un-
detectable at any time when the bacterial inoculum was supple-
mented with iron (10MFeSO4) (Fig. 4; see Fig. S2). Upon visual
comparison, more fluorescence was associated with the pvdA
pchD mutant than with wild-type PAO1 (Fig. 4; see Fig. S2), as
expected for a siderophore-null mutant, which experiences more
pronounced iron starvation, thus showing increased expression of
the reporter system. Most importantly, these in vivo experiments
demonstrate that P. aeruginosa perceives the mouse lung as an
iron-poor environment at the onset of infection.
Contributions of individual iron uptake systems to P.
aeruginosa lung infectivity. Wild-type PAO1 and all iron trans-
port mutants were tested for pathogenicity by use of a well-estab-
lished model of mouse pneumonia (31, 33). Mortality due to sec-
ondary septicemia was monitored for up to 14 days after the
challenge.
Almost all mice infected with wild-type PAO1 died within 7
days postinfection (10% survival). The feoB, hasR phuR, and pchD
mutant strains also caused relatively high mortality, with 20% to
45%mouse survival rates (Fig. 5), while both the tonB1 and tonB1
feoB strains were completely avirulent in this infectionmodel (Fig.
5). Notably, mice infected with pvdA and pvdA pchD strains dis-
played 77% and 85% survival rates, respectively (Fig. 5). These
results signify that among P. aeruginosa iron uptake systems, py-
overdine has the most prominent role and is required for success-
ful mouse lung infection.
Dual roles of pyoverdine inmouse lung infection. Interaction
of ferripyoverdine with the FpvA receptor triggers a signal
through the inner-membrane-spanning anti-sigma factor FpvR,
leading to the activation of the alternative sigma factor PvdS (21,
26). As summarized in Fig. 6A, PvdS controls, either directly or
indirectly, not only the pyoverdine synthesis genes but also the
expression of key P. aeruginosa virulence genes, such as the prpL
and toxA genes, encoding the PrpL endoprotease and exotoxin A,
respectively (26). Therefore, pyoverdine serves both as an iron
carrier in vivo and as an activating signal ofP. aeruginosa virulence.
Given these dual roles, an attempt was made to distinguish be-
tween the siderophore and virulence-inducing signal functions
of pyoverdine in vivo. For this purpose, we generated a pvdA
fpvR double mutant as well as an fpvR single mutant (as a
control). In the fpvR mutants, PvdS activity is not repressed by
the FpvR anti-sigma factor, and therefore PvdS-dependent vir-
ulence genes (prpL and toxA) are expressed irrespective of the
activation state of the pyoverdine signaling cascade. In fact, the
pvdA mutant was found to release lower levels of the PrpL and
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ToxA virulence factors due to the lack of ferripyoverdine sig-
naling via FpvA, while the introduction of the fpvRmutation in
the pvdA background restored the in vitro production of PrpL
and ToxA (Fig. 6B and C). The levels of the virulence factors in
culture supernatants correlated well with the -galactosidase
activities expressed by reporter plasmids carrying the PprpL or
PtoxA promoter (Fig. 6D).
In themousemodel of infection, the pvdAmutant was strongly
impaired in virulence, resulting in nearly the same lethality as that
of the pvdS mutant, which produces neither pyoverdine nor py-
overdine-induced virulence factors (25, 26, 59). Conversely, the
pvdA fpvRmutant showed significantly increased virulence (about
60% lethality) compared to that of the pvdA mutant. Since the
pvdA fpvR mutant was defective in pyoverdine-mediated iron
uptake, its increased pathogenicity compared to that of the
pvdA mutant could be ascribed to the restored production of
PvdS-dependent virulence factors due to the fpvR mutation
(Fig. 6E). This observation provides the first direct evidence
that pyoverdine contributes to the pathogenesis of P. aeruginosa
lung infection by combining iron transport and virulence-induc-
ing capabilities.
DISCUSSION
Iron is an essential nutrient for bacterial pathogens. To cope with
the iron limitation that characterizes healthy host tissues, patho-
genic bacteria must actively acquire iron through high-affinity
transport mechanisms. Accordingly, numerous data providing
evidence of the role of iron uptake in bacterial pathogenicity were
provided over years (reviewed in references 6 and 60). Themajor-
ity of bacterial pathogens are genetically determined to acquire
iron from several iron sources, including endogenous and exoge-
nous siderophores, heme or heme-binding proteins, and the sol-
uble Fe2 ion. However, the hierarchy according to which indi-
vidual iron uptake systems contribute to in vivo virulence is not
always clear.
Here we used a mouse model of pulmonary infection to assess
the roles of different iron acquisition systems in lung pathogenic-
ity by P. aeruginosa, which represents a typical example of an op-
FIG 3 P. aeruginosa growth in the presence of human transferrin. The wild type (WT) and the iron uptakemutants were grown inDCAA supplemented with 2.5
mg/ml human transferrin (A) and in complement-free human serum (B) for up to 48 and 56 h, respectively, in the absence (left panels, white symbols) or
presence (right panels, gray symbols) of 100 M FeCl3. For each strain, the mean value SD for three independent microtiter plate assays was considered.
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portunistic pathogen endowedwith broad ironuptake capabilities
(7, 8). By generating and testing single and double deletion mu-
tants in all the iron uptake systems described so far, we confirmed
that Fe3 acquisition is essential for P. aeruginosa infectivity in the
mouse pneumonia model, as testified by the avirulent phenotype
of mutants lacking the TonB energy transduction system for Fe3
transport across the outer membrane (Fig. 5). Among Fe3
sources, endogenous siderophores appear to be more important
than heme, since mice infected with the heme uptake-defective
hasR phuR double mutant showed lethality nearly comparable to
that with the wild type and opposite from that with the pyover-
dine- and pyochelin-deficient double mutant, which showed an
avirulent behavior resembling that of the tonB1mutant(s) (Fig. 5).
Impaired pyoverdine production had a stronger impact than pyo-
chelin deficiency onP. aeruginosa lung pathogenicity (Fig. 5). This
effect cannot be ascribed exclusively to more favorable iron-bind-
ing properties of pyoverdine than of pyochelin but also to the
crucial role of pyoverdine as a virulence-activating signalmolecule
(21, 26). The generation of a pyoverdine-deficient strain in which
the expression of the virulence factors PrpL and ToxA is indepen-
dent of pyoverdine signaling (pvdA fpvR)made it possible to dem-
onstrate that pyoverdine actually contributes to pathogenicity in
the mouse lung infection model through iron uptake and viru-
lence induction activities (Fig. 6). Interestingly, the lethalities ob-
served for the pchD (pyochelin) and pvdA fpvR (pyoverdine) mu-
tants were nearly comparable (ca. 50%), suggesting that both
pyochelin and pyoverdine provide important contributions to
FIG 4 The pvdA pchDmutant perceives themouse lung as an iron-poor environment. Confocal microscopy images showing the in vitro and in vivo fluorescence
of the pvdApchDmutant carrying the PpvdA=-=mCherry fusion. Bacterial cultureswere grown in the iron-poormediumDCAA, observed by confocalmicroscopy
(0 h), and diluted to obtain 6 108 CFU/ml. For the in vitro experiment, bacteria were grown in DCAA supplemented or not with 10 M FeSO4, and samples
were analyzed after 5 h and 24 h. For the in vivo experiment, mice were inoculated with a bacterial suspension in PBS supplemented or not with 10 M FeSO4.
After 5 h and 24 h of infection, BALs were performed, and BAL fluid was analyzed by confocal microscopy. Panels show pictures taken under visible light with
differential interference contrast (DIC) (a), the fluorescence emission upon excitation at 585 nm (b), and the overlay of visible and fluorescence images (c).
Representative images are shown. A Leica SP5 confocal laser scanning microscope equipped with a 63 oil immersion objective was used.
FIG 5 Iron uptake and P. aeruginosa virulence in a mouse model of pulmo-
nary infection. Mice were infected intratracheally with 2  106 P. aeruginosa
cells of wild-type (WT) PAO1 or of each iron uptakemutant embedded in agar
beads. Mortality was monitored for 14 days after challenge. Data were pooled
from two independent experiments (values for n indicate total numbers of
mice). The statistical significance of differences in survival curves with respect
to theWT are indicated as follows (Mantel-Cox test): *, P 0.05; **, P 0.01;
***, P 0.001; and NS, not statistically significant.
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siderophore-mediated iron uptake in the lung (Fig. 5 and 6). This
is an intriguing result considering the significantly lower affinity
for iron of pyochelin than that of pyoverdine, at least in vitro (9,
10, 12, 13). Since it has been demonstrated that pyoverdine has a
primary role in withdrawing iron from transferrin and lactoferrin
(61, 62) and is essential for P. aeruginosa growth in human serum
(Fig. 3) (56, 57), as well as for pathogenicity in a mouse model of
systemic infection (29), our data suggest that specific features of
the lung environment somehow foster the iron-chelating activity
of pyochelin during pulmonary infection. Notably, expression of
pyochelin genes was recently documented for P. aeruginosa cells
infecting the lungs of CF patients (55), and pyochelin production
was found to be induced in a CF epidemic strain in artificial CF
sputum medium (63).
Note that the mouse model used in this study, established by
PAO1 infection, was characterized by severe pneumonia (Fig. 5
and 6) (31) and multiorgan dissemination of bacterial cells (with
P. aeruginosa counts of 103 in spleens of moribund mice [data
not shown]), which led to fulminant sepsis and a high mortality
rate (80 to 90%). These conditions resemble those of acute P.
FIG 6 Pyoverdine signaling and P. aeruginosa lung pathogenicity. (A) Schematic of pyoverdine signaling. (Left) In the absence of ferripyoverdine, the TonB-
dependent FpvA receptor cannot transmit a signal to the membrane-spanning anti-sigma factor FpvR, which retains the sigma factors PvdS and FpvI in an
inactive state. (Right) Binding of ferripyoverdine determines a conformational change in the FpvA receptor that triggers FpvR proteolysis and release of the PvdS
and FpvI sigma factors, which can bind the core RNA polymerase (cRNAP) and initiate transcription. PvdS-dependent RNAP directs the transcription of
pyoverdine synthesis genes, the endoprotease PrpL gene (prpL), and, indirectly, the exotoxinA gene (toxA). FpvI-dependent RNAP transcribes the receptor FpvA
gene (fpvA). In the absence of the anti-sigma factor FpvR (i.e., in the pvdA fpvRmutant strain), PvdS is predicted to be constitutively active. Multiple arrows on
the pathway denote a multistep regulation. (B and C) PrpL enzymatic units (E.U.) (B) and exotoxin A levels (expressed as percentages relative to the level in
PAO1) (C) in supernatants from wild-type PAO1 (WT), pvdA, fpvR, and pvdA fpvR cultures grown for 16 h in TSBD. For Western blot analysis, the undiluted
supernatant and two 1:2 serial dilutions were loaded into the gels for each strain, while the undiluted supernatant from a toxA mutant was used as a negative
control. (D) -Galactosidase activities in WT, pvdA, fpvR, and pvdA fpvR cells carrying the pPZ-toxA (black bars) or pPZ-prpL (gray bars) promoter-probe
plasmid after 16 h of growth in TSBD. Values in panels B to D represent themeans SD for at least three independent experiments. Asterisks denote statistically
significant differences relative to theWT (*, P 0.05; **, P 0.01; ***, P 0.001) (ANOVA). (E) Virulence of theWT, pvdA, pvdA fpvR, and pvdS strains in the
mouse model of pulmonary infection. Data were pooled from two independent experiments (values for n indicate the total numbers of mice). The statistical
significance of differences in survival curves with respect to the WT are indicated as follows (Mantel-Cox test): *, P 0.05; and ****, P 0.0001.
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aeruginosa pneumonia in humans, which is associated with high
mortality and can eventually degenerate into septicemia (1, 2).
This pathological situation differs greatly from chronic lung infec-
tions established by P. aeruginosa in CF patients, which can partly
be mimicked in mice by using pathoadaptive CF isolates capable
of persisting in the lungs without causing death (34). Indeed, the
constitutive inflammatory state which characterizes the airways of
CF patients as a result of chronic bacterial infections (64) makes
CF lungs a completely different environment from the lungs of
healthy individuals. While iron is barely detectable in normal air-
way secretions, sputa from chronically infected CF patients con-
tain micromolar concentrations of iron (65, 66). This increase in
total iron probably derives from tissue damage due to the com-
bined actions of inflammation and infection, as well as by defec-
tive iron trafficking by CF epithelial cells (67). Thus, the interplay
between the host and the infecting pathogen(s) changes the lung
pathophysiology in CF patients, and this likely results in the avail-
ability of iron sources which are unavailable in healthy lungs. This
is indirectly corroborated by the observation that while pyover-
dine is essential for establishing infection in our mouse model of
acute pneumonia (Fig. 5 and 6), pyoverdine-deficient isolates ac-
cumulate over the course of chronic infection in CF patients (68–
70). Although many of these isolates can still behave as sidero-
phore cheaters, exploiting the supply of pyoverdine provided by
cooperative producers in mixed P. aeruginosa populations (70),
recent evidence strongly suggests that other iron acquisition strat-
egies can be employed by P. aeruginosa to persist in the chronically
infected CF lung. Notably, it has been found that the soluble Fe2
ion represents the main iron source in late-stage CF disease (71),
when oxygen tension in the lung is very low and P. aeruginosa
grows mainly as dense, biofilm-like microcolonies in locally an-
oxicmicroenvironments (72). Conversely, themaster regulator of
the pyoverdine system, PvdS, was previously shown to be required
for infection of tissues preferentially exposed to high O2 tensions
(30). Thus, although the feoBmutant displayed a slightly reduced
ability to cause infection compared to the wild-type strain in our
animal model (Fig. 5), the role of Feo in iron acquisition may
become more relevant during chronic CF infection or under any
other conditionwhereO2 tensions are low and Fe
2 represents the
main iron species. Accordingly, a recent real-time PCR analysis
detected feoBmRNA in the sputa of all CF patients analyzed (55).
Intriguingly, our in vitro results showed that P. aeruginosa feoB
and tonB1 deletion mutants retained the ability to grow under
anaerobic conditions when Fe2 represented the prevalent form
of iron (Fig. 2), strongly suggesting that an alternative (Feo-inde-
pendent) mechanism for Fe2 internalization exists in P. aerugi-
nosa. Fe2 uptake systems different from Feo have been described
for other bacteria, such as the EfeUOB and FetMP systems of E.
coli or the FtrABCD system of Bordetella pertussis, all belonging to
the same protein family as the Saccharomyces cerevisiae Ftr1 iron
transporter (73–75). Bioinformatic searches for homologs of the
inner membrane transporters EfeU, FetM, and FtrC revealed the
presence of a gene (PA5248) in the P. aeruginosa PAO1 genome
encoding a putative Frt1-like Fe2/Pb2 permease, which is pres-
ent in allPseudomonas species sequenced so far, with the exception
of P. fulva and P. stutzeri (www.pseudomonas.com). Whether
PA5248 accounts for the retained ability of a P. aeruginosa feoB
mutant under low-oxygen reducing conditions remains to be es-
tablished. Very recently, a novel putative siderophore system
which plays important roles in P. aeruginosa viability in vitro in
airway mucus secretions and in infectivity in burn wound and
airway infectionmousemodelswas identified (76), supporting the
hypothesis that still unexplored iron uptake functions may be en-
coded by the P. aeruginosa genome.
Besides Fe2, two independent studies recently observed that
reduction of pyoverdine production in different P. aeruginosa iso-
lates from late chronic CF infections is accompanied by a more
efficient utilization of heme as an iron source, suggesting that P.
aeruginosa can evolve toward heme acquisition during CF lung
colonization, plausibly as a consequence of increased availability
of hemoglobin (77, 78). Finally, it should be noted that both ex-
perimental evidence and bioinformatic predictions revealed that
P. aeruginosa has an impressive capability to acquire iron from
several xenosiderophores (reviewed in reference 21). Thus, it can-
not be excluded that in polymicrobial communities, such as those
transiently occurring in the lungs of CF patients (79), other exog-
enous iron chelators may contribute to P. aeruginosa persistence
and pathogenicity.
In conclusion, this work provides evidence that iron acquisi-
tion during acute P. aeruginosa lung infection is multifactorial,
with individual iron uptakemechanisms contributing to different
extents to the success of the pathogenic process. Moreover, the
essential role of TonB-mediated iron uptake in the establishment
of lung infection and the prominent contribution of the pyover-
dine siderophore to in vivo virulence further support the recent
efforts directed toward targeting iron metabolism and/or pyover-
dine to exploit alternative therapeutic strategies for the treatment
of P. aeruginosa infections (31, 80, 81).
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